Alkermes ALKS
NASDAQ ALKS
$45.38 -0.12 (-0.25%)
As of: Sep 9, 2026 · 3:27 PM EDT

Alkermes (ALKS) Other financing activities (2010 - 2026)

Alkermes' (ALKS) quarterly Other financing activities came in at $26.3 million in Q2 2026, up 1162.22% year-over-year from $2.1 million in Q2 2025, and up 67.32% quarter-over-quarter from $15.7 million in Q1 2026.

Analysis

Alkermes (ALKS) Other financing activities (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Other financing activities for 17 consecutive years, with $26.3 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other financing activities rose 1162.22% year-over-year to $26.3 million in Q2 2026; TTM through Jun 2026 was $53.8 million, a 18.65% increase from a year earlier, with the FY2025 full-year figure at $43.4 million, up 57.45% from the prior year.
  • Other financing activities was $26.3 million for Q2 2026 at Alkermes, up from $15.7 million in the prior quarter.
  • Over five years, Other financing activities peaked at $29.5 million in Q1 2025 and troughed at $622000.0 in Q3 2025.
  • A 5-year average of $8.3 million and a median of $4.3 million in 2023 frame the typical range for Other financing activities.
  • Across the five-year window, Other financing activities plunged 88.73% in 2025 and soared 1162.22% in 2026, its largest moves.
  • Over 5 years, Other financing activities stood at $780000.0 in 2022, then surged by 111.15% to $1.6 million in 2023, then jumped by 398.97% to $8.2 million in 2024, then surged by 36.02% to $11.2 million in 2025, then jumped by 135.21% to $26.3 million in 2026.
  • The last three Other financing activities figures came in at $26.3 million (Q2 2026), $15.7 million (Q1 2026), and $11.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.93 Bn 625.17 Bn 17.26 Bn
2 AbbVie 443.06 Bn 436.49 Bn 12.70 Bn
3 Merck 365.76 Bn 358.62 Bn 12.21 Bn
4 Novartis Ag 266.47 Bn 258.78 Bn 11.24 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn
6 Sanofi 52.36 Bn 44.98 Bn 10.79 Bn
7 Revolution Medicines 43.97 Bn 43.97 Bn -
8 Incyte 25.42 Bn 20.88 Bn 1.57 Bn
9 United Therapeutics 21.52 Bn 18.86 Bn 683.80 Mn
10 Alkermes 7.58 Bn 6.93 Bn 397.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.29 Mn
Mar 31, 2026 15.71 Mn
Dec 31, 2025 11.18 Mn
Sep 30, 2025 622,000.00
Jun 30, 2025 2.08 Mn
Mar 31, 2025 29.53 Mn
Dec 31, 2024 8.22 Mn
Sep 30, 2024 5.52 Mn
Jun 30, 2024 2.61 Mn
Mar 31, 2024 11.23 Mn
Dec 31, 2023 1.65 Mn
Sep 30, 2023 3.11 Mn
Jun 30, 2023 9.13 Mn
Mar 31, 2023 2.87 Mn
Dec 31, 2022 780,000.00
Sep 30, 2022 858,000.00
Jun 30, 2022 16.20 Mn
Mar 31, 2022 1.80 Mn
Dec 31, 2021 509,000.00
Sep 30, 2021 4.31 Mn